Vizimpro is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Dacomitinib.
Product ID | 0069-0197_470f74a3-f9ef-4a24-9bcd-aa54a3538ea9 |
NDC | 0069-0197 |
Product Type | Human Prescription Drug |
Proprietary Name | Vizimpro |
Generic Name | Dacomitinib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2018-10-04 |
Marketing Category | NDA / NDA |
Application Number | NDA211288 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | DACOMITINIB |
Active Ingredient Strength | 15 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-10-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA211288 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-10-04 |
Ingredient | Strength |
---|---|
DACOMITINIB | 15 mg/1 |
SPL SET ID: | 4ab27d2f-e385-4e9c-b324-fa69c10b855a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0069-0197 | Vizimpro | dacomitinib |
0069-1198 | Vizimpro | dacomitinib |
0069-2299 | Vizimpro | dacomitinib |
63539-197 | Vizimpro | dacomitinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VIZIMPRO 85979594 4401809 Live/Registered |
Pfizer Inc. 2010-12-08 |
VIZIMPRO 85193224 not registered Dead/Abandoned |
PF PRISM C.V. 2010-12-08 |
VIZIMPRO 77235981 not registered Dead/Abandoned |
Pfizer Inc. 2007-07-23 |